fosinopril has been researched along with Diabetic Retinopathy in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Han, Y; Li, Y; Sun, P; Xu, N | 1 |
Chen, H; Gu, Q; Li, C; Xu, X; Zheng, Z | 1 |
2 other study(ies) available for fosinopril and Diabetic Retinopathy
Article | Year |
---|---|
Destruction of the blood-retina barrier in diabetic retinopathy depends on angiotensin-converting enzyme-mediated TGF-β1/Smad signaling pathway activation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cells, Cultured; Coculture Techniques; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Cells; Ependymoglial Cells; Fosinopril; Male; Peptidyl-Dipeptidase A; Pyrazoles; Pyrroles; Rats; Rats, Sprague-Dawley; Retina; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1 | 2020 |
Effects of angiotensin-converting enzyme inhibitors and beta-adrenergic blockers on retinal vascular endothelial growth factor expression in rat diabetic retinopathy.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Basement Membrane; Blotting, Western; Capillaries; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Eye Proteins; Fosinopril; Immunohistochemistry; Male; Microscopy, Electron; Propranolol; Rats; Rats, Sprague-Dawley; Retina; Retinal Vessels; Reverse Transcriptase Polymerase Chain Reaction; Vascular Endothelial Growth Factor A | 2007 |